Sarcopenia prevalence in recovered of COVID-19 patients.
M. Salgado Fernández (México City, Mexico), D. González Islas (México City, Mexico), A. Orea Tejeda (México City, Mexico), C. Sánchez Moreno (México City, Mexico), S. Hernández López (México City, Mexico), S. Galicia Amor (México City, Mexico), R. Hernández Zenteno (México City, Mexico), V. Peláez Hernández (México City, Mexico), O. Vázquez Díaz (México City, Mexico), J. Orozco Gutiérrez (México City, Mexico)
Source: Virtual Congress 2021 – COVID - 19
Session: COVID - 19
Session type: E-poster
Number: 3476
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Salgado Fernández (México City, Mexico), D. González Islas (México City, Mexico), A. Orea Tejeda (México City, Mexico), C. Sánchez Moreno (México City, Mexico), S. Hernández López (México City, Mexico), S. Galicia Amor (México City, Mexico), R. Hernández Zenteno (México City, Mexico), V. Peláez Hernández (México City, Mexico), O. Vázquez Díaz (México City, Mexico), J. Orozco Gutiérrez (México City, Mexico). Sarcopenia prevalence in recovered of COVID-19 patients.. 3476
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: